Andrew S. Verderame, MBA, RAC leads the PharmaLex US staff in providing FDA-specific regulatory guidance and consulting services. PharmaLex clients benefit from his wealth of experience, including leading well over one hundred meetings with FDA, managing multi-site regulatory teams for both large and small pharmaceutical companies, and presenting to FDA Advisory Committees, with successful outcomes. He previously held senior regulatory affairs positions at EMD Serono, Replidyne, and Bayer.